Feasibility Study of Photovaporisation of Prostate With a Limitated Length of Catheterization of 3 Hours

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 2, 2015

Primary Completion Date

August 21, 2019

Study Completion Date

June 8, 2021

Conditions
Benign Prostatic Hypertrophy
Interventions
OTHER

Catheter

The effectiveness of this model of management is defined by absence of a need for re-catheterization in the post -operative period of 24 hours, indications for resondage being cases of acute urinary retention (AUR ) or macroscopic hematuria necessitating a washes with drainage . Patients are followed for a period of 3 months with a post-operative visit at 30 days and a last follow-up visit at 90 days during which the effectiveness is evaluated by conventional means of clinical indicators ( flowmetry , postvoid residue, volumetry of the prostate , IPSS scores , QoL , EVA, IIEF ... ).

Trial Locations (12)

2609

CHU Brest Urologie, Brest

13005

APHM - Urologie - Hôpital Conception, Marseille

22003

CH privé St Brieuc, Saint-Brieuc

38043

CHU Grenoble, Grenoble

51726

Polyclinique les Bleuets, Reims

CHU Rennes, Rennes

75020

AP-HP - Urologie Hôpital Tenon, Paris

75674

Institut Mutualiste Monsouris urologie, Paris

87042

CHU Limoges -Urologie - Hôpital Dupuytren, Limoges

06130

CH Grasse - urologie, Grasse

06200

CHU de Nice - Urologie, Nice

37 044

CHRU Tours, Tours

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT02401581 - Feasibility Study of Photovaporisation of Prostate With a Limitated Length of Catheterization of 3 Hours | Biotech Hunter | Biotech Hunter